Market cap
₹3 Cr
Revenue (TTM)
₹-- Cr
P/E Ratio
--
P/B Ratio
-0.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | 75.00 | 25.00 | -122.22 | 20.68 | 11.36 |
| Net Profit | 75.00 | 25.00 | -335.29 | 25.44 | 10.83 |
| EPS | 74.77 | 24.32 | -335.03 | 25.44 | 10.85 |
| Book Value | -- | -- | -0.01 | -2.97 | -2.14 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-17 | Mar-16 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -460.34 | -- | -- | -- |
| Return on equity
| 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Return on Capital
| -46.22 | -29.87 | -- | 0.00 | 0.00 |
| Return on Assets
| -63.29 | -39.64 | -363.64 | -12.17 | -70.55 |
| Debt to Equity (x)
| -- | -- | -0.99 | -0.99 | -0.99 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
--
|
--
|
--
|
-138.65
|
-5.33
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3.48
|
--
|
--
|
--
|
--
|
ROA
-363.64
Lower than Peers by 365.13
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
-363.64
|
-12.17
|
-70.55
|
-107.14
|
-4.29
|
|
Peer Median
|
1.49
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
--
|
-3.58
|
-16.09
|
-6,421.41
|
-611.31
|
|
Peer Median
|
2.79
|
--
|
--
|
--
|
--
|
EBIT Growth
-122.22
Lower than Peers by 130.39
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
-122.22
|
41.09
|
57.62
|
-3.14
|
7.52
|
|
Peer Median
|
8.16
|
--
|
--
|
--
|
--
|
Net Profit Growth
-335.29
Lower than Peers by 357.37
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
-335.29
|
85.33
|
99.44
|
-1,152.72
|
-5.17
|
|
Peer Median
|
22.08
|
--
|
--
|
--
|
--
|
EPS Growth
-335.03
Lower than Peers by 351.55
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
-335.03
|
85.90
|
99.44
|
-1,152.69
|
-5.17
|
|
Peer Median
|
16.52
|
--
|
--
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
--
|
-0.01
|
0.17
|
-9.23
|
-0.74
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-0.99
Lower than Peers by 0.99
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
-0.99
|
-0.99
|
-0.99
|
-0.99
|
-1.14
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
--
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
--
|
--
|
0.01
|
0.02
|
0.03
|
|
Peer Median
|
2.90
|
--
|
--
|
--
|
--
|
Quick Ratio
--
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
--
|
--
|
0.01
|
0.02
|
0.03
|
|
Peer Median
|
2.38
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
10.50
|
--
|
--
|
--
|
--
|
Operating Efficiency
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-17
|
Mar-16
|
Mar-15
|
Mar-14
|
|---|---|---|---|---|---|
|
Standard Medical & Pharm
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.34
|
--
|
--
|
--
|
--
|